Melphalan
Quick Overview
| Attribute | Value |
|---|---|
| Drug Name | Melphalan |
| DrugBank ID | DB01042 |
| KG Predictions | 44 |
| DL Predictions (≥0.7) | 187 |
| Evidence Level | L5 |
| NPRA Status | Approved |
Sample Brand Names in Malaysia
Predicted Indications
This drug has 44 knowledge graph predictions and 187 high-confidence deep learning predictions.
Top KG Predictions
| Indication | Source |
|---|---|
| ovarian clear cell adenocarcinoma | KG |
| hereditary breast ovarian cancer syndrome | KG |
| primary non-gestational choriocarcinoma of ovary | KG |
| ovarian carcinosarcoma | KG |
| malignant Sertoli-Leydig cell tumor of ovary | KG |
| familial ovarian cancer | KG |
| malignant sex cord stromal tumor of ovary | KG |
| malignant non-dysgerminomatous germ cell tumor of ovary | KG |
| malignant dysgerminomatous germ cell tumor of ovary | KG |
| ovarian endometrioid adenocarcinoma | KG |
FHIR Resources
Access drug data via FHIR R4 API:
- MedicationKnowledge:
/fhir/MedicationKnowledge/DB01042
Related Resources
| Resource | Link |
|---|---|
| DrugBank | View on DrugBank |
| PubMed | Search PubMed |
| ClinicalTrials.gov | Search Trials |
Disclaimer
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.